ArticlePloS one2025
An interpretable and balanced machine learning framework for Parkinson's disease prediction using feature engineering and explainable AI.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence and Digital Biomarkers for Early Detection and Monitoring of Neurological Disorders: A Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
- Self-Explaining Neural Networks for Transparent Parkinson's Disease Screening.Sensors (Basel, Switzerland) · 2026Article
- A multimodal explainable artificial intelligence framework for interpretable Parkinson's disease prediction.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a progressive neurological disorder that affects millions globally, posing significant challenges in early and accurate diagnosis. Recent advancements in machine learning (ML) offer promising approaches for addressing these challenges by enabling more precise and efficient PD predictions. This paper proposes an enhanced ML framework for PD prediction, integrating data balancing, feature selection, and explainable AI techniques. We evaluate nine different ML algorithms using a dataset of clinical and voice features. To address the class imbalance, we employ the Synthetic Minority Oversampling Technique (SMOTE) and NearMiss, comparing results to an imbalanced baseline. Feature engineering approaches, including Featurewiz, Tree based Feature Importance and the chi-square test, are utilized to identify key predictive features such as Pitch Period Entropy (PPE), Noise-to-Harmonic Ratio (NHR), and other voice biomarkers. Explainable AI (XAI) techniques (SHAP and LIME) interpret model decision-making and highlight influential features. The best-performing model, KNN with SMOTE, achieved 92% accuracy, F1-score 0.94, and a G-Mean of 0.95-demonstrating balanced, reliable PD detection. While some models achieved higher accuracy on imbalanced data (up to 97%), their performance lacked sensitivity and balance. Our findings suggest that combining SMOTE with feature engineering and XAI substantially enhances model fairness, performance, and interpretability. This research advances PD prediction by providing an accurate and interpretable ML-based diagnostic tool to support early diagnosis and better patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.